BMC Cancer

official impact factor 3.15

Open Access Email this article to a friend

Prospective study of daily low-dose nedaplatin and continuous 5-fluorouracil infusion combined with radiation for the treatment of esophageal squamous cell carcinoma

Satoshi Osawa*, Takahisa Furuta, Ken Sugimoto, Takashi Kosugi, Tomohiro Terai, Mihoko Yamade, Yasuhiro Takayanagi, Masafumi Nishino, Yasushi Hamaya, Chise Kodaira, Takanori Yamada, Moriya Iwaizumi, Kosuke Takagaki, Ken-ichi Yoshida, Shigeru Kanaoka and Mutsuhiro Ikuma

BMC Cancer 2009, 9:408 doi:10.1186/1471-2407-9-408

Fields marked * are required


Multiple email addresses should be separated with commas or semicolons.